Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
Plos One
|
March 21, 2014
The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer
Ethan V Abel, Edward J Kim, Jingjiang Wu, et al.
The Journal of Biological Chemistry
|
April 2, 2011
Protein kinase Czeta mediates micro-opioid receptor-induced cross-desensitization of chemokine receptor CCR5
Changcheng Song, Rahil T Rahim, Penelope C Davey, et al.
Annals of Surgical Oncology
|
November 30, 2016
Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes?
Filip Bednar, Mazen S Zenati, Jennifer Steve, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
August 26, 2010
The effect of smoking on biliary complications following liver transplantation
Amit K Mathur, David N Ranney, Shaun P Patel, et al.
Advances in Radiation Oncology
|
December 4, 2023
Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer
Rishi Das, Madeline R Abbott, Scott W Hadley, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
November 15, 2024
Mouse Models for Pancreatic Ductal Adenocarcinoma are Affected by the cre-driver Used to Promote KRAS<sup>G12D</sup> Activation
Fatemeh Mousavi, Joyce Thompson, Justine Lau, et al.
Plos One
|
December 11, 2012
Metastatic pancreatic cancer is dependent on oncogenic Kras in mice
Meredith A Collins, Jean-Christophe Brisset, Yaqing Zhang, et al.
The American Journal of Gastroenterology
|
March 27, 2024
Early Gastric Signet Ring Cell Adenocarcinoma as a Flat Pale Patch on an Esophagogastroduodenoscopy
Will Takakura, Shanti Eswaran, William D Chey, et al.
Cancer Research
|
October 8, 2013
Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance
Yaqing Zhang, Wei Yan, Meredith A Collins, et al.
Cancer Immunology Research
|
May 6, 2014
CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice
Yaqing Zhang, Wei Yan, Esha Mathew, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
Plos One
|
March 21, 2014
The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer
Ethan V Abel, Edward J Kim, Jingjiang Wu, et al.
The Journal of Biological Chemistry
|
April 2, 2011
Protein kinase Czeta mediates micro-opioid receptor-induced cross-desensitization of chemokine receptor CCR5
Changcheng Song, Rahil T Rahim, Penelope C Davey, et al.
Annals of Surgical Oncology
|
November 30, 2016
Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes?
Filip Bednar, Mazen S Zenati, Jennifer Steve, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
August 26, 2010
The effect of smoking on biliary complications following liver transplantation
Amit K Mathur, David N Ranney, Shaun P Patel, et al.
Advances in Radiation Oncology
|
December 4, 2023
Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer
Rishi Das, Madeline R Abbott, Scott W Hadley, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
November 15, 2024
Mouse Models for Pancreatic Ductal Adenocarcinoma are Affected by the cre-driver Used to Promote KRAS<sup>G12D</sup> Activation
Fatemeh Mousavi, Joyce Thompson, Justine Lau, et al.
Plos One
|
December 11, 2012
Metastatic pancreatic cancer is dependent on oncogenic Kras in mice
Meredith A Collins, Jean-Christophe Brisset, Yaqing Zhang, et al.
The American Journal of Gastroenterology
|
March 27, 2024
Early Gastric Signet Ring Cell Adenocarcinoma as a Flat Pale Patch on an Esophagogastroduodenoscopy
Will Takakura, Shanti Eswaran, William D Chey, et al.
Cancer Research
|
October 8, 2013
Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance
Yaqing Zhang, Wei Yan, Meredith A Collins, et al.
Cancer Immunology Research
|
May 6, 2014
CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice
Yaqing Zhang, Wei Yan, Esha Mathew, et al.
Page
of 7